MX386919B - Composiciones, métodos y kits para el diagnóstico de una neoplasia neuroendocrina gastroenteropancreática. - Google Patents
Composiciones, métodos y kits para el diagnóstico de una neoplasia neuroendocrina gastroenteropancreática.Info
- Publication number
- MX386919B MX386919B MX2017003370A MX2017003370A MX386919B MX 386919 B MX386919 B MX 386919B MX 2017003370 A MX2017003370 A MX 2017003370A MX 2017003370 A MX2017003370 A MX 2017003370A MX 386919 B MX386919 B MX 386919B
- Authority
- MX
- Mexico
- Prior art keywords
- gep
- nen
- methods
- compositions
- kits
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462050465P | 2014-09-15 | 2014-09-15 | |
| PCT/US2015/050274 WO2016044330A1 (en) | 2014-09-15 | 2015-09-15 | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017003370A MX2017003370A (es) | 2017-11-22 |
| MX386919B true MX386919B (es) | 2025-03-19 |
Family
ID=54207775
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017003370A MX386919B (es) | 2014-09-15 | 2015-09-15 | Composiciones, métodos y kits para el diagnóstico de una neoplasia neuroendocrina gastroenteropancreática. |
| MX2021012347A MX2021012347A (es) | 2014-09-15 | 2017-03-14 | Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021012347A MX2021012347A (es) | 2014-09-15 | 2017-03-14 | Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica. |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10407730B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3194618B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6782700B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102762958B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107208132A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2015317893B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2959670C (cg-RX-API-DMAC7.html) |
| DK (2) | DK3929303T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES3013599T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL250867B (cg-RX-API-DMAC7.html) |
| MX (2) | MX386919B (cg-RX-API-DMAC7.html) |
| PL (2) | PL3194618T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016044330A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102762958B1 (ko) | 2014-09-15 | 2025-02-04 | 클리프톤 라이프 사이언시즈 엘엘씨 | 위장관췌장 신경내분비 신생물의 진단을 위한 조성물, 방법 및 키트 |
| BR112019024481A2 (pt) * | 2017-05-25 | 2020-07-14 | Liquid Biopsy Research LLC | métodos para detecção de melanoma |
| PL3717667T3 (pl) * | 2017-11-30 | 2025-06-23 | Liquid Biopsy Research LLC | Przewidywanie radioterapii receptora peptydowego za pomocą testu ekspresji genów |
| CN108048564B (zh) * | 2018-02-09 | 2021-03-05 | 中国科学院昆明动物研究所 | 人glt8d1基因的新用途 |
| WO2020027732A1 (en) * | 2018-07-30 | 2020-02-06 | Agency For Science, Technology And Research | Method and system for assessing fibrosis in a tissue sample |
| CN114901819A (zh) | 2019-10-10 | 2022-08-12 | 液体活检研究有限责任公司 | 用于生物样品和rna稳定化的组合物、方法和试剂盒 |
| FR3110764B1 (fr) * | 2020-05-20 | 2024-05-10 | Quantum Surgical | Méthode de prédiction de la récidive d’une lésion par analyse d’images |
| CN113215255B (zh) * | 2021-04-26 | 2022-04-05 | 山东天川精准医疗科技有限公司 | 用于肝癌早期诊断或预后的生物标记物及其用途 |
| AU2023308345A1 (en) * | 2022-07-15 | 2025-02-27 | Emendobio Inc. | Strategies for knock-ins at aplp2 safe harbor sites |
| KR20250080875A (ko) * | 2022-09-30 | 2025-06-05 | 리퀴드 바이옵시 리서치 엘엘씨 | 타액에서 신경내분비암을 검출하는 방법 |
| CN117292755B (zh) * | 2023-08-09 | 2026-02-06 | 郑州大学 | 多模态临界边生物标志物识别方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005020795A2 (en) | 2003-08-25 | 2005-03-10 | The Johns Hopkins University | Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differntial gene expression analysis |
| CA2727082C (en) | 2008-06-12 | 2019-02-26 | Syntaxin Limited | Fusion proteins for use in suppression of acromegaly |
| KR102023584B1 (ko) * | 2011-03-01 | 2019-09-24 | 예일 유니버시티 | 위장관췌장 신경내분비 신생물 (GEP-NENs)의 예측 방법 |
| KR102762958B1 (ko) | 2014-09-15 | 2025-02-04 | 클리프톤 라이프 사이언시즈 엘엘씨 | 위장관췌장 신경내분비 신생물의 진단을 위한 조성물, 방법 및 키트 |
-
2015
- 2015-09-15 KR KR1020177010086A patent/KR102762958B1/ko active Active
- 2015-09-15 AU AU2015317893A patent/AU2015317893B2/en active Active
- 2015-09-15 PL PL15771837T patent/PL3194618T3/pl unknown
- 2015-09-15 DK DK21169154.8T patent/DK3929303T3/da active
- 2015-09-15 CN CN201580061761.0A patent/CN107208132A/zh active Pending
- 2015-09-15 ES ES21169154T patent/ES3013599T3/es active Active
- 2015-09-15 JP JP2017533744A patent/JP6782700B2/ja active Active
- 2015-09-15 EP EP15771837.0A patent/EP3194618B1/en active Active
- 2015-09-15 DK DK15771837.0T patent/DK3194618T3/da active
- 2015-09-15 US US14/855,229 patent/US10407730B2/en active Active
- 2015-09-15 MX MX2017003370A patent/MX386919B/es unknown
- 2015-09-15 ES ES15771837T patent/ES2881474T3/es active Active
- 2015-09-15 PL PL21169154.8T patent/PL3929303T3/pl unknown
- 2015-09-15 EP EP21169154.8A patent/EP3929303B1/en active Active
- 2015-09-15 WO PCT/US2015/050274 patent/WO2016044330A1/en not_active Ceased
- 2015-09-15 CA CA2959670A patent/CA2959670C/en active Active
- 2015-09-15 KR KR1020257003150A patent/KR20250021631A/ko active Pending
-
2017
- 2017-03-01 IL IL250867A patent/IL250867B/en active IP Right Grant
- 2017-03-14 MX MX2021012347A patent/MX2021012347A/es unknown
-
2019
- 2019-08-01 US US16/528,864 patent/US11168372B2/en active Active
-
2020
- 2020-10-20 JP JP2020175701A patent/JP7157788B2/ja active Active
-
2021
- 2021-03-09 IL IL281355A patent/IL281355B/en unknown
- 2021-08-06 AU AU2021212151A patent/AU2021212151B2/en active Active
- 2021-11-08 US US17/521,205 patent/US12258633B2/en active Active
-
2023
- 2023-11-03 AU AU2023258444A patent/AU2023258444A1/en active Pending
-
2025
- 2025-03-05 US US19/071,035 patent/US20260043085A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX386919B (es) | Composiciones, métodos y kits para el diagnóstico de una neoplasia neuroendocrina gastroenteropancreática. | |
| BR112019004075A2 (pt) | métodos para diagnosticar um indivíduo com suspeita de endometriose, para detectar mirna, para diagnosticar um indivíduo que apresenta sintomas de endometriose ou com suspeita de endometriose, para tratar um indivíduo com endometriose, para diagnosticar e tratar um indivíduo com suspeita de endometriose, para diagnosticar endometriose em um indivíduo, para diagnosticar ou prover um prognóstico para endometriose em um indivíduo e para monitorar uma resposta a um tratamento de endometriose em um indivíduo, e, kit. | |
| MX2017008421A (es) | Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga. | |
| MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
| MX390772B (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
| MX360236B (es) | Uso de marcadores en el diagnostico y tratamiento de cancer de prostata. | |
| MX2016002423A (es) | Composiciones y metodos de diagnostico para el tratamiento de glioblastoma. | |
| ES2721907T3 (es) | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal | |
| WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
| EA201790769A1 (ru) | Определение уровней гликозаминогликанов методом масс-спектрометрии | |
| MX2016012285A (es) | Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf. | |
| MX2015012303A (es) | Un metodo no invasivo para medir el estres oxidativoy daño oxidativo de los biomarcadores cutaneos. | |
| MX380642B (es) | Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv). | |
| BR112016016101A2 (pt) | Métodos para determinar o estado do distúrbio inflamatório, para monitorar a progressão de uma doença inflamatória ou monitorar a eficácia de um tratamento, kit, e, uso da determinação da presença, ou do nível, de tesnacina-c citrulinada e/ou um ou mais fragmentos de tesnacina-c citrulinada e/ou de autoanticorpos com especificidade para os mesmos | |
| MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
| IN2014DE01077A (cg-RX-API-DMAC7.html) | ||
| MX388231B (es) | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| WO2016089732A3 (en) | Methods and compositions for diagnosis and management of diabetes and metabolic syndrome | |
| BR112017025995A2 (pt) | inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal | |
| MX377026B (es) | Biomarcadores para la progresión de enfermedades en melanoma. | |
| HK1232238A1 (zh) | 检测人类骨膜蛋白的新型测定 | |
| BR112012024175A2 (pt) | hbf e a1m como marcadores de estágio precoce para preeclampsia | |
| EP3502271A3 (en) | Blood biomarkers for appendicitis and diagnostics methods using biomarkers | |
| WO2016112174A3 (en) | Biomarkers of Sleep Deprivation and Cognitive Impairment | |
| WO2017156154A9 (en) | Compositions for characterizing development of esophageal adenocarcinoma in patients and methods of use thereof |